Informação sobre produto
MS1943 is a monoclonal antibody that binds to the HER2 receptor and inhibits the growth of breast cancer cells. MS1943 is currently in clinical trials for its potential use as a biomarker in patients with HER2+ breast cancer. The drug has been shown to bind to a variety of targets, including response elements and intracellular targets. It also binds to both the extracellular domain of the HER2 receptor and the intracellular domain of the HER2 receptor. MS1943 binds to many different subunits, including dimeric forms of HER2 receptors, which may be responsible for its success against certain types of breast cancers.
Propriedades químicas
Consulta técnica sobre: 3D-APD93817 MS1943
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
